News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kona Medical Announces Initiation of WAVE I Study of Renal Denervation Therapy for Hypertension



10/23/2012 9:09:03 AM

BELLEVUE, Wash. & MENLO PARK, Calif.--(BUSINESS WIRE)--Kona Medical, Inc. (www.konamedical.com) today announced the initiation of the first clinical study of its device therapy for drug-resistant hypertension. The Kona Surround SoundTM system utilizes focused ultrasound, delivered from outside the body, to treat the nerves leading to and from the kidney. The therapy of renal denervation has been shown in other studies to lead to significant and lasting reductions in high blood pressure. Kona is sponsoring the WAVE I clinical study to evaluate the safety and efficacy of its novel technology. WAVE I is now enrolling subjects at St. Vincent’s Hospital in Melbourne, Australia, under the direction of Primary Investigator Robert Whitbourn, MD. The study design and initial results of WAVE I will be presented on behalf of the investigators by Todd Brinton, MD on Wednesday, October 24th at the Transcatheter Cardiovascular Therapeutics conference in Miami, Florida.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES